Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Avery Dennison, 3M Settle Patent And Antitrust Litigation - Quick Facts

RELATED NEWS
Trade AVY now with 

Avery Dennison Corp. (AVY: Quote) announced the settlement of its patent and antitrust litigation with 3M company. Avery said the company will continue to sell its OmniCube products worldwide.

The litigation began when 3M alleged that Avery Dennison infringed its patents and sought a preliminary injunction to prevent Avery from selling OmniCube, a Type XI sheeting product used to increase nighttime visibility of road signs and other highway and transportation products. The court denied 3M's request, and after Avery Dennison brought claims of its own for patent infringement and antitrust violations, the companies agreed to dismiss all three pending cases.

Click here to receive FREE breaking news email alerts for Avery Dennison Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After ending the previous session modestly lower, stocks are turning in a lackluster performance in early trading on Thursday. The major averages have turned mixed on the day, with the Dow benefiting from a strong gain by shares of Visa (V). Hundreds of protesters stormed Burkina Faso's parliament on Thursday and set fire to the building, preventing the lawmakers from considering a bill to extend the president's 27-year rule. Security forces opened fire on protesters, as they looted computers and televisions in the National Assembly, news agencies reported. The angry crowd then marched towards the President's office, before they were U.S. economic activity increased by more than expected in the third quarter of 2014, according to a report released by the Commerce Department on Thursday. The Commerce Department said GDP increased by 3.5 percent in the third quarter compared to 3.0 percent growth expected by economists.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.